Gene expression is complicated, including modulation from upstream promoter regions, epigenetic alterations, protein synthesis staging and cellular packaging, and with these complex steps, this widens the possibilities for SOD1 and other gene targets for successful therapeutic approaches in ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.